Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 1/20 | 0.39 |
| ▸ | HCRTR1 | O43613 | 3/20 | 0.38 |
| ▸ | HCRTR2 | O43614 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 4/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
| ▸ | SLC5A1 | P13866 | 2/20 | 0.38 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31444317 | 0.90 | SLC5A2 (0.40) | RORCHCRTR1HCRTR2MEN1KMT2A | |
| SCHEMBL31444354 | 0.84 | MEN1 (0.39) | HCRTR1HCRTR2MEN1KMT2ASLC5A1 | |
| SCHEMBL31444335 | 0.83 | SLC5A1 (0.41) | RORCHCRTR1HCRTR2MEN1KMT2A | |
| SCHEMBL18151549 | 0.81 | MEN1 (0.50) | HCRTR1HCRTR2MEN1KMT2AALDH1A1 | |
| SCHEMBL31444487 | 0.78 | HCRTR2 (0.56) | RORCHCRTR1HCRTR2MEN1KMT2A | |
| SCHEMBL18150873 | 0.70 | MEN1 (0.50) | HCRTR1HCRTR2MEN1KMT2AALDH1A1 | |
| SCHEMBL18159810 | 0.70 | MEN1 (0.50) | HCRTR1HCRTR2MEN1KMT2AALDH1A1 | |
| SCHEMBL15989606 | 0.70 | MDM2 (0.51) | HCRTR1HCRTR2MEN1KMT2ANPSR1 | |
| SCHEMBL15972180 | 0.70 | MDM2 (0.51) | HCRTR1HCRTR2MEN1KMT2ANPSR1 | |
| SCHEMBL15989605 | 0.70 | MDM2 (0.51) | HCRTR1HCRTR2MEN1KMT2ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025072451-A1 | RAS-PI3K INHIBITORS FOR THE TREATMENT OF CANCER AND IMMUNOLOGICAL DISEASES | VIVIDION THERAPEUTICS, INC. (US) | 2025-04-03 | — | — | WO | disclosed |